Patient guide · Reviewed May 2026
Thyroid Monitoring on GLP-1 Medications — What the Warning Means
Every Ozempic, Wegovy, and Mounjaro packet includes a thyroid warning. It alarms many patients — but the wording is specific, and for the vast majority of Australians the risk in humans remains theoretical rather than proven.
This guide explains the C-cell tumour finding in animal studies, who must not take GLP-1 medications, and what TSH monitoring involves in routine Australian practice.
This is not medical advice. Do not start or stop medication based on this article alone.
Published 2026-05-01 · Clinically reviewed 2026-05-31
Patient guide · Reviewed May 2026
The Thyroid C-Cell Warning — In Plain Language
Semaglutide and tirzepatide caused thyroid C-cell tumours (medullary thyroid cancer type) in rodents at exposures higher than used in humans. It is unknown…
Semaglutide and tirzepatide caused thyroid C-cell tumours (medullary thyroid cancer type) in rodents at exposures higher than used in humans. It is unknown whether GLP-1 receptor agonists cause these tumours in people.
Product information therefore lists medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia syndrome type 2 (MEN2) as contraindications — meaning you should not take Ozempic, Wegovy, or Mounjaro if you or a close family member have these conditions.
For everyone else, the warning is a precaution: report neck lumps, hoarseness, difficulty swallowing, or persistent sore throat to your doctor promptly.
Contraindications — Who Should Not Use GLP-1s
- Personal or family history of medullary thyroid carcinoma.
- Personal history of MEN2 (includes familial medullary thyroid cancer syndromes).
- Known hypersensitivity to semaglutide, tirzepatide, or excipients.
- Pregnancy and breastfeeding — GLP-1 medications are not recommended.
Papillary and follicular thyroid cancers — the common types — are not the same as medullary thyroid cancer and are not automatic contraindications, but discuss your history with your endocrinologist.
Patient guide · Reviewed May 2026
TSH Monitoring in Practice
TSH (thyroid stimulating hormone) is the standard blood test for thyroid function. GLP-1 medications can modestly affect weight and metabolism but do not…
TSH (thyroid stimulating hormone) is the standard blood test for thyroid function. GLP-1 medications can modestly affect weight and metabolism but do not replace thyroid hormone treatment if you have hypothyroidism.
- Baseline TSH before starting therapy (or use a recent result within 12 months).
- Repeat annually, or sooner if symptoms of hypo- or hyperthyroidism develop.
- If you take levothyroxine, continue regular TSH monitoring — weight loss may change your dose requirement.
Routine neck ultrasound for all GLP-1 patients is not recommended unless you have symptoms or thyroid nodules under specialist follow-up.
Symptoms to Report
- Lump in the front of the neck or enlarged lymph nodes.
- Persistent hoarse voice not explained by infection.
- Difficulty swallowing or breathing lying flat.
- Unexplained diarrhoea or flushing (rare medullary thyroid cancer symptoms).
These symptoms are usually benign — thyroid nodules are common — but they warrant examination, not reassurance from an internet search.
Find a liver elastography clinic near you
Search by suburb or postcode to see accredited clinics offering FibroScan and guided liver elastography across Australia.
Type a suburb or postcode and press Enter to search nearby.
Request a liver scan appointment
Submit your details and we'll route your request to the most appropriate elastography clinic in your area. Most clinics respond within 1–2 business days.
Take action
Request an appointment
Frequently asked questions
Should I be scared of the thyroid cancer warning on Ozempic?
The warning reflects animal data and theoretical risk, not proven human epidemic. Absolute contraindication applies only to medullary thyroid cancer and MEN2. Discuss personal and family thyroid history with your prescriber.
Do I need a thyroid ultrasound every year?
Not routinely. Annual TSH blood test is standard for many patients. Ultrasound is reserved for symptoms, nodules, or specialist protocols.
I have Hashimoto's disease — can I still take Mounjaro?
Autoimmune hypothyroidism (Hashimoto's) is not a contraindication. Continue levothyroxine and monitor TSH as weight changes on GLP-1 therapy.
Does Wegovy have the same thyroid warning as Ozempic?
Yes — both contain semaglutide and share the same class precaution regarding C-cell tumours in rodents.
What blood test checks my thyroid on GLP-1?
TSH is the first-line screen. Free T4 (and sometimes free T3) may be added if TSH is abnormal or you have symptoms.
Reviewed against: TGA product information Ozempic, Wegovy, Mounjaro; FDA labels semaglutide and tirzepatide thyroid safety sections; EMA public assessment reports; ATA guidelines on thyroid nodule evaluation.
This article is for educational purposes only. It does not constitute medical advice. Always consult your GP or a specialist about your individual health circumstances.
Next step
Find a liver elastography clinic near you
Search participating clinics across Australia, or talk to your GP about a baseline FIB-4 and elastography.